Singapore Therapeutics Development Review
Funds the funds therapeutic projects covering small molecules, large molecules, cell and gene therapies, and platform technologies.
The Singapore Therapeutics Development Review (STDR) funds therapeutic R&D projects covering small molecules, large molecules, cell and gene therapies, and platform technologies. Two tracks are available: Pre-Pilot (up to S$325K, for earlier-stage proof-of-concept work including target validation and platform development) and Pilot (up to S$1M, for projects with sufficient research data and some v…
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.
Funds selected therapeutic development projects through A*STAR STDR Pilot support for small molecules, biologics, and cell therapy.
Funds early-stage therapeutic proof-of-concept research in Singapore across multiple modalities.